Adenylate kinase 2 is a biomarker related to the prognosis of glioma and the immune microenvironment.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of clinical laboratory analysis"
DOI: 10.1002/jcla.24892
Abstract: BACKGROUND Among the brain and the other central nervous system, gliomas are the most prevalent malignant primary tumors. Adenylate kinase 2 (AK2) is generally thought to be crucial for energy metabolism and signal transduction. Several… read more here.
Keywords: immune microenvironment; expression; glioma; ak2 expression ... See more keywords